"10.1371_journal.pone.0039320","plos one","2012-06-22T00:00:00Z","Fei Wu; Dan Huang; Lisha Wang; Qinghua Xu; Fang Liu; Xun Ye; Xia Meng; Xiang Du","Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China; Institut Mérieux Laboratory, Fudan University Shanghai Cancer Center, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China","Conceived and designed the experiments: XM XD. Performed the experiments: FW DH LW. Analyzed the data: FW. Contributed reagents/materials/analysis tools: FL XY DH. Wrote the paper: FW QX XM.","The authors have the following interest: FW, QX, FL, XY and XM are the employees of bioMérieux company. THEROS CancerTYPE ID is marketed by bioMérieux. There are no patents or other products in development to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","06","Fei Wu","FW",8,TRUE,2,3,1,3,TRUE,TRUE,FALSE,0,NA,FALSE
